Advances in the Understanding and Management of Chiari I Malformation: From Structural Anomaly to Multidimensional Disorder

Abstract

Background: Chiari I malformation (CM-I) has traditionally been defined as a structural abnormality characterized by caudal displacement of the cerebellar tonsils below the foramen magnum. However, increasing use of advanced neuroimaging and the recognition of asymptomatic cases have challenged this purely anatomical definition. Emerging evidence suggests that CM-I represents a heterogeneous disorder involving cerebrospinal fluid (CSF) dynamics, craniovertebral morphology, and genetic factors.
Methods: A systematic review was conducted according to PRISMA 2020. PubMed/MEDLINE, Scopus, and Web of Science were searched for English-language human studies published from January 1, 2000,to March 31, 2026. Studies addressing pathophysiology, imaging, classification, natural history, or management of CM-I were included. Due to heterogeneity in study design, populations, imaging protocols, and outcomes, a qualitative synthesis was performed.
Results: A total of 124 studies were included in the qualitative synthesis. Current evidence demonstrates that symptom severity in CM-I correlates poorly with the degree of tonsillar descent, highlighting the limitations of traditional diagnostic thresholds. Disruption of CSF flow at the craniovertebral junction has emerged as a central mechanism underlying symptom development and syringomyelia formation. AI-driven analyses have been explored as tools to identify potential phenotypic subgroups and may improve prognostic stratification. Longitudinal studies indicate that while many patients remain stable, a subset experiences progressive neurological decline associated with identifiable risk factors. Surgical management, particularly posterior fossa decompression, remains the primary treatment for symptomatic patients, with evolving techniques aimed at reducing morbidity and improving outcomes.
Conclusion: Chiari I malformation is increasingly recognized as a multifactorial and heterogeneous condition rather than a purely structural anomaly. Integration of advanced imaging, computational modeling, and clinical data is essential for accurate diagnosis and individualized management. Future research should focus on refining phenotypic classification, identifying predictive biomarkers, and advancing precision medicine approaches to optimize patient outcomes.